Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Dash0 | $9,500,000 | (Nov 5, 2024)
Geneos Therapeutics
United States
- Plymouth Meeting, PA
- 13/04/2023
- Series A
- $5,000,000
At Geneos, our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our GT-EPIC Platform is designed to identify relevant neoantigen targets and then design, manufacture, and deliver tumor specific neoantigen-targeted personalized immunotherapies.
- Industry Biotechnology Research
- Website https://www.geneostx.com/
- LinkedIn https://www.linkedin.com/company/geneos-therapeutics/
Related People
Niranjan SardesaiCo Founder
United States -
Blue Bell, Pennsylvania
Executive experienced in developing talent and commercializing technologies for the bio-pharmaceutical and diagnostics marketplace. Strong record in product development and R&D. Particular expertise in:
• Start-up environments and R&D pipeline development
• Corporate financing and M&A
• Organizational development: Hiring and retaining talent
• Valuation of technology and partnering/licensing
• Product development: Vaccines and therapeutics for infectious diseases and oncology
• cGMP environment and regulatory aspects for medical devices and biologics; combination products
• Management of cross-functional and cross-organizational teams
Authored over 120+ peer-reviewed publications/book chapters; presented over 120+ invited lectures/presentations; and inventor on 10+ issued and 70+ patent applications filed/pending US/global
Honored by Pharmavoice Magazine as one of the top 100 most influential and inspirational people from across the Lifesciences and Healthcare Industry (2015)
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)